Site Map

IsoRay sales, net losses decrease in Q2

Report: ARRA to dampen PACS, RIS, CVIS markets

Breast MRI screening benefits women with rad therapy history

FDA clears TomTec's 4D cardiac software

Study tracks gadolinium adverse events; CAD for US and VC

ACR to accredit Siemens FFDM

Teledyne wraps up DALSA purchase

IMRIS reports Q4 rise in sales, earnings

U-Systems touts US breast screening study

Obama's 2012 budget includes 2-year SGR fix

Neoprobe reaches clinical study goal

Interactive US CAD aids in characterizing breast lesions

Study finds few adverse events with gadolinium contrast

Page 1 of 1